Clinical Trial Update: Study Evaluating Combination of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) in Premenstrual Dysphoric Disorder [Phase 3]

View source ↗

Summary

The document notes the completion of a Phase 3 trial evaluating a levonorgestrel/ethinyl estradiol combination for Premenstrual Dysphoric Disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premenstrual Dysphoric Disorder
• Premenstrual Syndrome

Drugs mentioned

• Levonorgestrel/ethinyl estradiol (Levonorgestrel/ethinyl estradiol)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Menstruation Disturbances, Premenstrual Syndrome | Phase 3 | Status: COMPLETED